Christopher T Lam1, Marlee S Krieger2, Jennifer E Gallagher3, Betsy Asma4, Lisa C Muasher5, John W Schmitt5, Nimmi Ramanujam2. 1. Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America. 2. Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America; Center for Global Women's Health Technologies, Duke University, Durham, North Carolina, United States of America; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America. 3. Department of Surgery, Duke University, Durham, North Carolina, United States of America. 4. Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America. 5. Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, United States of America.
Abstract
INTRODUCTION: Current guidelines by WHO for cervical cancer screening in low- and middle-income countries involves visual inspection with acetic acid (VIA) of the cervix, followed by treatment during the same visit or a subsequent visit with cryotherapy if a suspicious lesion is found. Implementation of these guidelines is hampered by a lack of: trained health workers, reliable technology, and access to screening facilities. A low cost ultra-portable Point of Care Tampon based digital colposcope (POCkeT Colposcope) for use at the community level setting, which has the unique form factor of a tampon, can be inserted into the vagina to capture images of the cervix, which are on par with that of a state of the art colposcope, at a fraction of the cost. A repository of images to be compiled that can be used to empower front line workers to become more effective through virtual dynamic training. By task shifting to the community setting, this technology could potentially provide significantly greater cervical screening access to where the most vulnerable women live. The POCkeT Colposcope's concentric LED ring provides comparable white and green field illumination at a fraction of the electrical power required in commercial colposcopes. Evaluation with standard optical imaging targets to assess the POCkeT Colposcope against the state of the art digital colposcope and other VIAM technologies. RESULTS: Our POCkeT Colposcope has comparable resolving power, color reproduction accuracy, minimal lens distortion, and illumination when compared to commercially available colposcopes. In vitro and pilot in vivo imaging results are promising with our POCkeT Colposcope capturing comparable quality images to commercial systems. CONCLUSION: The POCkeT Colposcope is capable of capturing images suitable for cervical lesion analysis. Our portable low cost system could potentially increase access to cervical cancer screening in limited resource settings through task shifting to community health workers.
INTRODUCTION: Current guidelines by WHO for cervical cancer screening in low- and middle-income countries involves visual inspection with acetic acid (VIA) of the cervix, followed by treatment during the same visit or a subsequent visit with cryotherapy if a suspicious lesion is found. Implementation of these guidelines is hampered by a lack of: trained health workers, reliable technology, and access to screening facilities. A low cost ultra-portable Point of Care Tampon based digital colposcope (POCkeT Colposcope) for use at the community level setting, which has the unique form factor of a tampon, can be inserted into the vagina to capture images of the cervix, which are on par with that of a state of the art colposcope, at a fraction of the cost. A repository of images to be compiled that can be used to empower front line workers to become more effective through virtual dynamic training. By task shifting to the community setting, this technology could potentially provide significantly greater cervical screening access to where the most vulnerable women live. The POCkeT Colposcope's concentric LED ring provides comparable white and green field illumination at a fraction of the electrical power required in commercial colposcopes. Evaluation with standard optical imaging targets to assess the POCkeT Colposcope against the state of the art digital colposcope and other VIAM technologies. RESULTS: Our POCkeT Colposcope has comparable resolving power, color reproduction accuracy, minimal lens distortion, and illumination when compared to commercially available colposcopes. In vitro and pilot in vivo imaging results are promising with our POCkeT Colposcope capturing comparable quality images to commercial systems. CONCLUSION: The POCkeT Colposcope is capable of capturing images suitable for cervical lesion analysis. Our portable low cost system could potentially increase access to cervical cancer screening in limited resource settings through task shifting to community health workers.
Authors: E H Hopman; L Rozendaal; R H Verheijen; P Kenemans; T J Helmerhorst Journal: Eur J Obstet Gynecol Reprod Biol Date: 1998-04 Impact factor: 2.435
Authors: Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers Journal: CA Cancer J Clin Date: 2012-03-14 Impact factor: 508.702
Authors: Nicolas Wentzensen; Lauren Schwartz; Rosemary E Zuna; Katie Smith; Cara Mathews; Michael A Gold; R Andy Allen; Roy Zhang; S Terence Dunn; Joan L Walker; Mark Schiffman Journal: Clin Cancer Res Date: 2012-06-06 Impact factor: 12.531
Authors: Rengaswamy Sankaranarayanan; Parthasarathy Basu; Ramani S Wesley; Cédric Mahe; Namory Keita; Charles C Gombe Mbalawa; Rameshwar Sharma; Amadou Dolo; Surendra S Shastri; Marius Nacoulma; Madi Nayama; Thara Somanathan; Eric Lucas; Richard Muwonge; Lucien Frappart; D Maxwell Parkin Journal: Int J Cancer Date: 2004-07-20 Impact factor: 7.396
Authors: Jenna L Mueller; Elizabeth Asma; Christopher T Lam; Marlee S Krieger; Jennifer E Gallagher; Alaattin Erkanli; Roopa Hariprasad; J S Malliga; Lisa C Muasher; Bariki Mchome; Olola Oneko; Peyton Taylor; Gino Venegas; Anthony Wanyoro; Ravi Mehrotra; John W Schmitt; Nimmi Ramanujam Journal: J Low Genit Tract Dis Date: 2017-04 Impact factor: 1.925
Authors: Mercy Nyamewaa Asiedu; Anish Simhal; Usamah Chaudhary; Jenna L Mueller; Christopher T Lam; John W Schmitt; Gino Venegas; Guillermo Sapiro; Nimmi Ramanujam Journal: IEEE Trans Biomed Eng Date: 2018-12-18 Impact factor: 4.538
Authors: Karen Haney; Pushpa Tandon; Rao Divi; Miguel R Ossandon; Houston Baker; Paul C Pearlman Journal: IEEE J Transl Eng Health Med Date: 2017-11-23 Impact factor: 3.316
Authors: Robert Morhard; Jenna L Mueller; Qishun Tang; Corrine Nief; Erika Chelales; Christopher T Lam; Daniel Adrianzen Alvarez; Michael Rubinstein; David F Katz; Nimmi Ramanujam Journal: IEEE Trans Biomed Eng Date: 2019-12-16 Impact factor: 4.538
Authors: Derek Ho; Tyler K Drake; Karen K Smith-McCune; Teresa M Darragh; Loris Y Hwang; Adam Wax Journal: Int J Cancer Date: 2017-03-15 Impact factor: 7.396
Authors: Christine M O'Brien; Katherine J Cochran; Laura E Masson; Mack Goldberg; Eric Marple; Kelly A Bennett; Jeff Reese; James C Slaughter; J M Newton; Anita Mahadevan-Jansen Journal: J Biophotonics Date: 2018-10-29 Impact factor: 3.207